NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
NOVAQUEST CAPITAL MANAGEMENT, L.L.C. is a Series C+ and buyout fund in the US and Global writing $30M–$100M checks into Healthcare, life-sciences, biopharmaceuticals, animal-health and pharmaceuticals.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, life-sciences, biopharmaceuticals, animal-health, pharmaceuticals
- Check size
- $30M–$100M
- Invests in
- US-wide, Global
- Actively investing
- Yes
- Founded
- 2010
- Assets under management
- $3.0B
- Website
- novaquest.com
Thesis
NovaQuest Capital Management, L.L.C. is a private equity firm founded in 2010, based in Raleigh, North Carolina, specializing in life sciences, particularly biopharmaceuticals and animal health. Their core strategy is "PRODUCT FINANCE™," offering non-dilutive capital for late-stage clinical trials, product launches, and commercialization. They operate under a "One Health" philosophy, investing in companies that improve human and animal health, reduce healthcare costs, and address unmet medical needs. Their geographic focus is US and global, with investment stages including growth, late-stage, pre-IPO, and buyout. The firm manages over $3.0 billion in assets. They have a strong track record with 11 IPOs and 14 acquisitions. NovaQuest also identifies as an active ESG investor.
Common questions
Does NOVAQUEST CAPITAL MANAGEMENT, L.L.C. invest at the Series C+ stage?
Yes. NOVAQUEST CAPITAL MANAGEMENT, L.L.C. lists Series C+ and buyout among the stages it invests in.
What check size does NOVAQUEST CAPITAL MANAGEMENT, L.L.C. write?
NOVAQUEST CAPITAL MANAGEMENT, L.L.C. writes $30M–$100M checks.
Where does NOVAQUEST CAPITAL MANAGEMENT, L.L.C. invest?
NOVAQUEST CAPITAL MANAGEMENT, L.L.C. invests in the US and Global.